Coforge Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/stxkdzcm5ya9dnoqn39ydzad.pdf

Key Takeaways


Encora Acquisition: The AI-Infused Future Bet

Sudhir Singh: "It also sets us up as the tech services firm that is likely to be the first to deliver upon the promise of the AI infused future that lies ahead of our industry."

Demand Environment & Vertical Outlook

Sudhir Singh: "We believe Healthcare, Hi-tech, Public Sector will grow on steroids next year, if I were to put it euphemistically."

Margins: Wage Hit Absorbed, Recovery Path Set

Margin walk (QoQ)Impact
Wage hikes–150 bps
Margin initiatives + lower ESOP cost+90 bps
Hedge loss (adverse)–26 bps
Net change–60 bps
Saurabh Goel: "We are also now revisiting the hedging strategy wherein we will stop taking the cash flow hedges, which will then allow us to at least take the hedge gains or losses as part of the other income so that it does not impact our EBITDA or operational EBIT performance."

AI & Agentic Delivery: From Experimentation to Impact

Sudhir Singh: "The age of AI experimentation is over. What we are witnessing is a market inflection point."

Delivery Excellence & Operational Metrics


Cigniti Merger & Corporate Developments


Guidance & Commitments

CommitmentSpecificsTimeline
Q4 EBIT marginRegister 15% EBITQ4 FY26
FY26 EBIT margin14% EBIT for full yearFY26
Cigniti merger consummationApproval expected; merger complete by FY26 financials reportingBy March-end or before Q4 results
Encora regulatory approvalsHSR in Feb; all approvals between March and April; consolidation starts thenFeb–April 2026
Encora integration expenses\$10–\$15 mn in transaction, integration, and funding expensesNext two quarters
No EPS dilution from EncoraCombined business FY27 EPS not diluted even after debtFY27
FCF conversionSustained 70% to 80% of PATOngoing
Wage hike freezeNo wage hike for at least four quarters, supporting FY27 margin expansionNext four quarters minimum
Hedging strategy updateClarity on revised hedging approach expectedNext quarter

Key Metrics

MetricQ3 FY26
Revenue₹4,188.1 cr, +5.1% QoQ INR, +4.4% QoQ CC, +3.5% QoQ US\$
YTD US\$ revenue growth32.8%
EBIT margin13.4%, +191 bps YoY, -60 bps QoQ; wage hikes impact of 150 bps partially offset by margin initiatives and lower ESOP cost
Underlying EBIT margin (excl. hedge losses)14.4%
Q4 FY26 EBIT margin plan15%
FY26 EBIT margin guidance14%
EPS (excl. exceptional items)INR 10.9 per share for Q3; 9-month EPS INR 31.6, +83% YoY
Free cash flow\$45.7 mn, FCF to normalized PAT of 110%
Order intake\$593 mn
Executable order book (next 12 months)\$1.72 bn, 30% higher than same time last year
Large deals signed6 in Q3; 16 in first three quarters of FY26
Total headcount35,341, net addition of 445 during the quarter
Utilization81.8%
LTM attrition10.9%
Top 5 clients revenue contribution21.0% of Q3 revenue, grew 51% YTD in US\$ terms
Top 10 clients revenue contribution30.7% of Q3 revenue, grew 47% YTD in US\$ terms
Healthcare & Hitech vertical revenue share10.5% of total revenue, nearly doubled YTD
Hedge loss₹43.4 cr, adverse impact of 26 bps on reported EBIT, 90 bps impact on EBIT margins
Exceptional itemsINR 147 cr: INR 118 cr New Labour Code, INR 13.5 cr Encora acquisition expenses, INR 16.2 cr legal expenses for cybersecurity incident
Encora acquisition enterprise value\$2.35 bn, \$1.89 bn via share swap, balance via term loan; \$550 mn term loan for 3 years being finalized
Working capital cycle49 days (48 days in previous quarter); Billed DSO 67 days, unbilled 28 days, contract assets 14 days